How I treat patients with CLL after prior treatment with a covalent BTK inhibitor and a BCL-2 inhibitor. Shadman M, Davids MS. Blood 2025;146:2029-2036.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shadman M, Davids MS. How I treat patients with CLL after prior treatment with a covalent BTK inhibitor and a BCL-2 inhibitor. Blood 2025;146:2029-2036.
PMID: 40729699